Welcome!

Apache Authors: Carmen Gonzalez, Liz McMillan, Elizabeth White, Pat Romanski, Christopher Harrold

News Feed Item

India's Pharmaceutical Armada

GURGAON, India and MADRID, Spain, October 9, 2012 /PRNewswire/ --

Brand India Pharma in the Spotlight at CPhI Worldwide 2012

Having gained Focus Country status for CPhI exhibitions held globally, India the world's largest generic medicine manufacturer will be the cynosure of all eyes with its 'Brand India Pharma' campaign. The three-day CPhI Worldwide pharmaceuticals event will be held in Madrid from October 9-11.

     (Logo: http://photos.prnewswire.com/prnh/20121009/567525)

CPhI Worldwide is the largest pharmaceutical trade exhibition organised each year by the UBM Group. UBM recognised India as the Focus Country across the CPhI exhibitions it has been organising globally, beginning with CPhI Japan in March 2012 followed by CPhI South East Asia held in Jakarta in May 2012 and finally CPhI Worldwide, which follows in October this year.

CPhI Japan event, held during March 21-23, 2012 in Tokyo, was the launch-pad for the 'Brand India Pharma' campaign. The campaign is a significant initiative being led by Pharmexcil (Pharmaceutical Export Promotion Council of India) and IBEF (India Brand Equity Foundation) under the aegis of the Department of Commerce, Government of India, to highlight the value proposition that 'Brand India Pharma' presents today globally.

These events present an opportunity for various business groups for enhancing business growth in the pharmaceutical space by networking and thought sharing with leading pharmaceutical companies from across the globe brought together by CPhI. 

Participation from over 200 Indian pharmaceutical companies is expected at the Madrid event spread across all segments of the industry. The Indian presence at Madrid will be led by Mr. S R Rao, Commerce Secretary, Ministry of Commerce and Industry, Government of India, who will be accompanied by senior officials of the Department of Commerce and a large Indian business contingent.

With the global pharmaceutical market growing at 5%, India is making massive strides in the pharmaceutical sector by clocking a growth rate of 10%, double the global growth rate in the sector. According to a PricewaterhouseCoopers report, India's current pharmaceutical market size is around US$ 11 billion, global market size being US$ 880 billion, and is expected to reach US$ 74 billion by 2020.   

India has been exporting to regulated markets, which majorly comprises the US and the European Union, apart from Oceania and Japan. In the unregulated sector, Latin America, Africa and parts of Asia comprise of the market. While there is a huge potential in the regulated markets, the events of the past 3-4 years have demonstrated the necessity for diversification. India aims to double its exports to reach US$ 500 billion by 2014, the share of pharmaceutical exports is expected to be a robust 5% of the total target at US$ 25 billion.

At a sustained growth rate of 10%, India has arrived at the global pharmaceutical arena as a hub for all pharmaceutical manufacturing and research needs. Today, there are 475 USFDA (U.S. Food and Drug Administration) approved manufacturing facilities in India.

India's growing per-capita income, stable economy, and government's active support to the pharmaceutical sector, make India a very lucrative investment destination for pharmaceuticals businesses seeking newer growth opportunities.

Biocon, Dr. Reddy's Laboratories, and Aurobindo Pharma are some leading Indian companies in the pharmaceutical domain registering annual revenue of close to US$ 1 billion each.

Pfizer (USA), GlaxoSmithKline (UK), Novartis (Switzerland), Bayer (Germany), Sanofi-Aventis (France), Johnson & Johnson (USA) are some of the leading international pharmaceutical companies having successful business presence in India.

India's rising disposable income, improving medical infrastructure, greater health insurance penetration, shift in disease profile, and growth in population will play a key role in ensuring India's dominance in the global pharmaceutical space in the days ahead. 

Additionally, the Government of India has undertaken various initiatives to bolster growth in the pharmaceutical sector. Specifically, steps like tax incentives and grants for bio-technology start-ups, permitting 100% FDI (Foreign Direct Investment) in pharmaceutical sector, and the unveiling of a plan to set up a Rs 2,000 crore venture capital fund to promote drug discovery and strengthen infrastructure have had far reaching effects in making 'Brand India Pharma' synonymous with quality, affordable and sustainable healthcare.

For further information please visit http://www.brandindiapharma.in/.

About India Brand Equity Foundation (IBEF):

India Brand Equity Foundation is a Trust established by the Ministry of Commerce with the Confederation of Indian Industry (CII) as its associate. IBEF's primary objective is to promote and create international awareness of the Made in India label in markets overseas and to facilitate the dissemination of knowledge of Indian products and services. IBEF is engaged in building Brand India. Towards this objective, IBEF works closely with stakeholders across government and industry.

Primary Media Contact: Aditi Thakur, [email protected], 91-9818143259

Secondary Media Contact: Pawan Chabra, [email protected], 91-124-4499600

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

IoT & Smart Cities Stories
The platform combines the strengths of Singtel's extensive, intelligent network capabilities with Microsoft's cloud expertise to create a unique solution that sets new standards for IoT applications," said Mr Diomedes Kastanis, Head of IoT at Singtel. "Our solution provides speed, transparency and flexibility, paving the way for a more pervasive use of IoT to accelerate enterprises' digitalisation efforts. AI-powered intelligent connectivity over Microsoft Azure will be the fastest connected pat...
There are many examples of disruption in consumer space – Uber disrupting the cab industry, Airbnb disrupting the hospitality industry and so on; but have you wondered who is disrupting support and operations? AISERA helps make businesses and customers successful by offering consumer-like user experience for support and operations. We have built the world’s first AI-driven IT / HR / Cloud / Customer Support and Operations solution.
Codete accelerates their clients growth through technological expertise and experience. Codite team works with organizations to meet the challenges that digitalization presents. Their clients include digital start-ups as well as established enterprises in the IT industry. To stay competitive in a highly innovative IT industry, strong R&D departments and bold spin-off initiatives is a must. Codete Data Science and Software Architects teams help corporate clients to stay up to date with the mod...
At CloudEXPO Silicon Valley, June 24-26, 2019, Digital Transformation (DX) is a major focus with expanded DevOpsSUMMIT and FinTechEXPO programs within the DXWorldEXPO agenda. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of business. Only 12% still survive. Similar percentages are found throug...
Druva is the global leader in Cloud Data Protection and Management, delivering the industry's first data management-as-a-service solution that aggregates data from endpoints, servers and cloud applications and leverages the public cloud to offer a single pane of glass to enable data protection, governance and intelligence-dramatically increasing the availability and visibility of business critical information, while reducing the risk, cost and complexity of managing and protecting it. Druva's...
BMC has unmatched experience in IT management, supporting 92 of the Forbes Global 100, and earning recognition as an ITSM Gartner Magic Quadrant Leader for five years running. Our solutions offer speed, agility, and efficiency to tackle business challenges in the areas of service management, automation, operations, and the mainframe.
The Jevons Paradox suggests that when technological advances increase efficiency of a resource, it results in an overall increase in consumption. Writing on the increased use of coal as a result of technological improvements, 19th-century economist William Stanley Jevons found that these improvements led to the development of new ways to utilize coal. In his session at 19th Cloud Expo, Mark Thiele, Chief Strategy Officer for Apcera, compared the Jevons Paradox to modern-day enterprise IT, examin...
With 10 simultaneous tracks, keynotes, general sessions and targeted breakout classes, @CloudEXPO and DXWorldEXPO are two of the most important technology events of the year. Since its launch over eight years ago, @CloudEXPO and DXWorldEXPO have presented a rock star faculty as well as showcased hundreds of sponsors and exhibitors! In this blog post, we provide 7 tips on how, as part of our world-class faculty, you can deliver one of the most popular sessions at our events. But before reading...
DSR is a supplier of project management, consultancy services and IT solutions that increase effectiveness of a company's operations in the production sector. The company combines in-depth knowledge of international companies with expert knowledge utilising IT tools that support manufacturing and distribution processes. DSR ensures optimization and integration of internal processes which is necessary for companies to grow rapidly. The rapid growth is possible thanks, to specialized services an...
At CloudEXPO Silicon Valley, June 24-26, 2019, Digital Transformation (DX) is a major focus with expanded DevOpsSUMMIT and FinTechEXPO programs within the DXWorldEXPO agenda. Successful transformation requires a laser focus on being data-driven and on using all the tools available that enable transformation if they plan to survive over the long term. A total of 88% of Fortune 500 companies from a generation ago are now out of business. Only 12% still survive. Similar percentages are found throug...